The dynamic nature of the kinome

被引:66
作者
Graves, Lee M. [1 ]
Duncan, James S. [1 ]
Whittle, Martin C. [1 ]
Johnson, Gary L. [1 ]
机构
[1] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
基金
美国国家卫生研究院;
关键词
CHRONIC MYELOID-LEUKEMIA; RECEPTOR TYROSINE KINASES; ACQUIRED-RESISTANCE; CHEMICAL PROTEOMICS; CELLULAR TARGETS; PROTEIN-KINASES; MEK INHIBITORS; CANCER KINOME; BREAST-CANCER; HEMATOLOGIC MALIGNANCIES;
D O I
10.1042/BJ20121456
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent advances in proteomics have facilitated the analysis of the kinome 'en masse'. What these studies have revealed is a surprisingly dynamic network of kinase responses to highly selective kinase inhibitors, thereby illustrating the complex biological responses to these small molecules. Moreover these studies have identified key transcription factors, such as c-Myc and FOXO (forkhead box O), that play pivotal roles in kinome reprogramming in cancer cells. Since many kinase inhibitors fail despite a high efficacy of blocking their intended targets, elucidating kinome changes at a more global level will be essential to understanding the mechanisms of kinase inhibitor pharmacology. The development of technologies to study the kinome, as well as examples of kinome resilience and reprogramming, will be discussed in the present review.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 98 条
[1]   Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity [J].
Anastassiadis, Theonie ;
Deacon, Sean W. ;
Devarajan, Karthik ;
Ma, Haiching ;
Peterson, Jeffrey R. .
NATURE BIOTECHNOLOGY, 2011, 29 (11) :1039-U117
[2]   Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors [J].
Bantscheff, Marcus ;
Eberhard, Dirk ;
Abraham, Yann ;
Bastuck, Sonja ;
Boesche, Markus ;
Hobson, Scott ;
Mathieson, Toby ;
Perrin, Jessica ;
Raida, Manfred ;
Rau, Christina ;
Reader, Valerie ;
Sweetman, Gavain ;
Bauer, Andreas ;
Bouwmeester, Tewis ;
Hopf, Carsten ;
Kruse, Ulrich ;
Neubauer, Gitte ;
Ramsden, Nigel ;
Rick, Jens ;
Kuster, Bernhard ;
Drewes, Gerard .
NATURE BIOTECHNOLOGY, 2007, 25 (09) :1035-1044
[3]   Mechanisms of drug resistance in kinases [J].
Barouch-Bentov, Rina ;
Sauer, Karsten .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (02) :153-208
[4]   From single cells to deep phenotypes in cancer [J].
Bendall, Sean C. ;
Nolan, Garry P. .
NATURE BIOTECHNOLOGY, 2012, 30 (07) :639-647
[5]   Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators [J].
Bodenmiller, Bernd ;
Zunder, Eli R. ;
Finck, Rachel ;
Chen, Tiffany J. ;
Savig, Erica S. ;
Bruggner, Robert V. ;
Simonds, Erin F. ;
Bendall, Sean C. ;
Sachs, Karen ;
Krutzik, Peter O. ;
Nolan, Garry P. .
NATURE BIOTECHNOLOGY, 2012, 30 (09) :858-U89
[6]   Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma [J].
Bollag, Gideon ;
Hirth, Peter ;
Tsai, James ;
Zhang, Jiazhong ;
Ibrahim, Prabha N. ;
Cho, Hanna ;
Spevak, Wayne ;
Zhang, Chao ;
Zhang, Ying ;
Habets, Gaston ;
Burton, ElizabethA. ;
Wong, Bernice ;
Tsang, Garson ;
West, Brian L. ;
Powell, Ben ;
Shellooe, Rafe ;
Marimuthu, Adhirai ;
Nguyen, Hoa ;
Zhang, Kam Y. J. ;
Artis, Dean R. ;
Schlessinger, Joseph ;
Su, Fei ;
Higgins, Brian ;
Iyer, Raman ;
D'Andrea, Kurt ;
Koehler, Astrid ;
Stumm, Michael ;
Lin, Paul S. ;
Lee, Richard J. ;
Grippo, Joseph ;
Puzanov, Igor ;
Kim, Kevin B. ;
Ribas, Antoni ;
McArthur, Grant A. ;
Sosman, Jeffrey A. ;
Chapman, Paul B. ;
Flaherty, Keith T. ;
Xu, Xiaowei ;
Nathanson, Katherine L. ;
Nolop, Keith .
NATURE, 2010, 467 (7315) :596-599
[7]   Proteome-wide identification of cellular targets affected by bisindolylmaleimide-type protein kinase C inhibitors [J].
Brehmer, D ;
Godl, K ;
Zech, B ;
Wissing, J ;
Daub, H .
MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (05) :490-500
[8]  
Brehmer D, 2005, CANCER RES, V65, P379
[9]   Feedback upregulation of HER3 (ErbB3) expression and activity attenuates antitumor effect of PI3K inhibitors [J].
Chakrabarty, Anindita ;
Sanchez, Violeta ;
Kuba, Maria G. ;
Rinehart, Cammie ;
Arteaga, Carlos L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (08) :2718-2723
[10]   AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity [J].
Chandarlapaty, Sarat ;
Sawai, Ayana ;
Scaltriti, Maurizio ;
Rodrik-Outmezguine, Vanessa ;
Grbovic-Huezo, Olivera ;
Serra, Violeta ;
Majumder, Pradip K. ;
Baselga, Jose ;
Rosen, Neal .
CANCER CELL, 2011, 19 (01) :58-71